Novel cytostatic 7-deazapurine nucleosides
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388963%3A_____%2F16%3A00471695" target="_blank" >RIV/61388963:_____/16:00471695 - isvavai.cz</a>
Result on the web
<a href="https://worldwide.espacenet.com/publicationDetails/biblio?CC=EP&NR=2231689B1&KC=B1&FT=D&ND=4&date=20160720&DB=&locale=en_EP#" target="_blank" >https://worldwide.espacenet.com/publicationDetails/biblio?CC=EP&NR=2231689B1&KC=B1&FT=D&ND=4&date=20160720&DB=&locale=en_EP#</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Novel cytostatic 7-deazapurine nucleosides
Original language description
The invention provides compounds of formula (I), wherein R1 and R2 have any of the values defined in the specification and salts thereof, as well as compositions comprising such compounds and therapeutic methods that utilize such compounds.
Czech name
—
Czech description
—
Classification
Type
P - Patent
CEP classification
CC - Organic chemistry
OECD FORD branch
—
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2016
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Patent/design ID
EP2231689
Publisher
EPO_1 -
Publisher name
European Patent Office
Place of publication
Munich, The Hague, Berlin, Vienna, Brussels
Publication country
—
Date of acceptance
Jul 20, 2016
Owner name
Ústav organické chemie a biochemie AV ČR, v. v. i
Method of use
A - Výsledek využívá pouze poskytovatel
Usage type
A - K využití výsledku jiným subjektem je vždy nutné nabytí licence